pre-seed
Stage
1
Investors
About
BioXplor develops AI-driven data analytics platforms to support drug discovery and improve clinical trial processes, with a focus on rare, inflammatory diseases, and cancer by using real-world evidence and advanced analytics.
Explore BioXplor's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.